The board of directors of Sihuan Pharmaceutical Holdings Group Ltd. announced the appointment of Dr. GUO Feng as Group Vice President (Research and Development). Dr. GUO will be primarily responsible for research and development division in the USA and clinical trial center. Dr. GUO brought to the Group nearly 20 years of experiences in innovative drug R&D and management especially in oncology drug R&D strategy making, clinical development, registration etc. In 2013, Dr. GUO joined Merck & Co. Inc. as Vice President of Global R&D and Head of Merck Biopharma (China) R&D Hub, a member of Merck Healthcare Global Clinical Development Executive Leadership team. Ms. JIA Zhongxin has retired recently as Chief Operating Officer of the Group.